Efficacy and Drug-Related Complications of Anticholinergic Drugs for Vagal Reaction Prevention During Pulsed Field Ablation
JACC: Clinical Electrophysiology · 2025
DOI: 10.1016/j.jacep.2025.04.015 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2025. Verfasst von Giampaolo Vetta und 31 weiteren Autor:innen. Beteiligte Einrichtung: Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brus…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cholinergic Antagonists, Glycopyrrolate, Atropine. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Vagal responses (VR) are frequently observed during pulmonary vein isolation (PVI) with pulsed field ablation (PFA). OBJECTIVES: The aim of this study was to compare the effectiveness of 2 different anticholinergic (AC) medications, namely glycopyrrolate (GLY) or atropine (ATP), for VR prophylaxis in patients undergoing PVI via a pentaspline PFA catheter. METHODS: Consecutive patients with atrial fibrillation undergoing first-time PVI with PFA were prospectively enrolled at 4 centers between April 2023 and March 2024. Intravenous GLY 0.2 mg (Group GLY) or ATP 1 mg (Group ATP) were administered prophylactically before transseptal access. Clinically relevant VRs included sinus bradycardia ( 6 seconds), atrioventricular block, and the need for temporary backup pacing. The incidence of periprocedural VRs was compared with that of patients without prophylactic AC drug administration (Group noAC). Drug-related adverse events were compared between the 2 AC drugs. RESULTS: We enrolled 240 patients (age 61 ± 12 years, 60.0% male) (GLY: n = 80; ATP: n = 80; noAC: n = 80). Intraprocedural VRs were observed in 65 patients (27.1%). GLY and ATP effectively reduced overall VRs (GLY: 7.5% vs ATP: 11.3% vs noAC: 62.5%; P < 0.001), asystole (GLY: 1.3% vs ATP: 2.5% vs noAC: 33.8%; P < 0.001), and need for temporary backup pacing (GLY: 1.3% vs ATP: 5.0% vs noAC: 23.8%; P < 0.001). The risk of overall drug-related adverse events (8.8% vs 0%; P = 0.007) and drug-induced atrial fibrillation (5% vs 0%; P = 0.043) was significantly higher with ATP. CONCLUSIONS: Prophylactic AC drug administration effectively prevented clinically relevant VRs in patients undergoing PVI with PFA. Both AC drugs were equally highly effective, but ATP showed a significantly higher rate of drug-induced adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium.
- Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium; Texas…
- Arrhythmology Unit, Ospedale Isola Tiberina-Gemelli Isola, Rome, Italy.
- Heart Rhythm Department, Clinique Pasteur, Toulouse, France.
- Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
- Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA; Department of Biomedicine and Prevention, "Tor Vergata" University of Rome, Rome, Italy; Interventional Electrophysiology, Scripps Clin…
Zitieren
APA
Vetta, G., Della Rocca, D. G., Magnocavallo, M., Richard-Vitton, R., Almorad, A., Betancur, A., Sorgente, A., Polselli, M., Marcon, L., Mohanty, S., Del Monte, A., Lombardo, I., Pannone, L., Mouram, S., Stroker, E., Gianni, C., La Fazia, V. M., Bianchi, S., Doundoulakis, I., …, & HRMC Investigators (2025). Efficacy and Drug-Related Complications of Anticholinergic Drugs for Vagal Reaction Prevention During Pulsed Field Ablation. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2025.04.015
Vancouver
Vetta G, Della Rocca DG, Magnocavallo M, Richard-Vitton R, Almorad A, Betancur A, et al. Efficacy and Drug-Related Complications of Anticholinergic Drugs for Vagal Reaction Prevention During Pulsed Field Ablation. JACC: Clinical Electrophysiology. 2025. doi:10.1016/j.jacep.2025.04.015
BibTeX
@article{Vetta2025,
author = {Vetta, Giampaolo and Della Rocca, Domenico G and Magnocavallo, Michele and Richard-Vitton, Robin and Almorad, Alexandre and Betancur, Andres and Sorgente, Antonio and Polselli, Marco and Marcon, Lorenzo and Mohanty, Sanghamitra and Del Monte, Alvise and Lombardo, Ilenia and Pannone, Luigi and Mouram, Sahar and Stroker, Erwin and Gianni, Carola and La Fazia, Vincenzo Mirco and Bianchi, Stefano and Doundoulakis, Ioannis and Overeinder, Ingrid and Audiat, Charles and Nakasone, Kazutaka and Bala, Gezim and Combes, Stephane and Sarkozy, Andrea and Sieira, Juan and Boveda, Serge and Rossi, Pietro and Natale, Andrea and de Asmundis, Carlo and Chierchia, Gian-Battista and HRMC Investigators, HRMC Investigators},
title = {Efficacy and Drug-Related Complications of Anticholinergic Drugs for Vagal Reaction Prevention During Pulsed Field Ablation},
journal = {JACC: Clinical Electrophysiology},
year = {2025},
doi = {10.1016/j.jacep.2025.04.015}
}
EUVIMED